Anna Jirkovská

Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation

Eduard Jirkovský, Anna Jirkovská, Hana Bavlovič Piskáčková et al. · Circulation Heart Failure · 2021 · 58 citations · Full text

Medicine, Cardiology, Pharmacology +17

Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury

Hana Jansová, Miloslav Macháček, Qin Wang et al. · Free Radical Biology and Medicine · 2014 · 30 citations

Medicine, Cardiology, Pharmacology +15

Investigation of novel dexrazoxane analogue JR-311 shows significant cardioprotective effects through topoisomerase IIbeta but not its iron chelating metabolite

Jan Bureš, Anna Jirkovská, Vít Šesták et al. · Toxicology · 2017 · 27 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Proteomic investigation of embryonic rat heart-derived H9c2 cell line sheds new light on the molecular phenotype of the popular cell model

Juraj Lenčo, Olga Lenčová-Popelová, Marek Link et al. · Experimental Cell Research · 2015 · 26 citations

Life Sciences, Cell Biology, Molecular Biology +9

Structure-Activity Relationships of Novel Salicylaldehyde Isonicotinoyl Hydrazone (SIH) Analogs: Iron Chelation, Anti-Oxidant and Cytotoxic Properties

Eliška Potůčková, Kateřina Hrušková, Jan Bureš et al. · PLoS ONE · 2014 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15